3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype.

      American Journal of Physiology - Lung Cellular and Molecular Physiology
      Animals, Atrial Natriuretic Factor, pharmacology, Cell Proliferation, Cells, Cultured, Collagen, metabolism, Cyclic GMP, Cyclic Nucleotide Phosphodiesterases, Type 5, genetics, Drug Combinations, Endothelium, Vascular, drug effects, enzymology, Humans, Immunoblotting, Immunoprecipitation, Laminin, Neovascularization, Physiologic, Phenotype, Phosphodiesterase 5 Inhibitors, Proteoglycans, Pulmonary Artery, RNA, Messenger, RNA, Small Interfering, Rats, Reverse Transcriptase Polymerase Chain Reaction

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Type 5 phosphodiesterase (PDE5) inhibitors increase endothelial cell cGMP and promote angiogenesis. However, not all endothelial cell phenotypes express PDE5. Indeed, whereas conduit endothelial cells express PDE5, microvascular endothelial cells do not express this enzyme, and they are rapidly angiogenic. These findings bring into question whether PDE5 activity is a critical determinant of the endothelial cell angiogenic potential. To address this question, human full-length PDE5A1 was stably expressed in pulmonary microvascular endothelial cells. hPDE5A1 expression reduced the basal and atrial natriuretic peptide (ANP)-stimulated cGMP concentrations in these cells. hPDE5A1-expressing cells displayed attenuated network formation on Matrigel in vitro and also produced fewer blood vessels in Matrigel plug assays in vivo; the inhibitory actions of hPDE5A1 were reversed using sildenafil. To examine whether endogenous PDE5 activity suppresses endothelial cell angiogenic potential, small interfering RNA (siRNA) constructs were stably expressed in pulmonary artery endothelial cells. siRNA selectively decreased PDE5 expression and increased basal and ANP-stimulated cGMP concentrations in these conduit cells. PDE5 downregulation increased network formation on Matrigel in vitro and increased blood vessel formation in Matrigel plug assays in vivo. Collectively, our results indicate that PDE5 activity is an essential determinant of angiogenesis and suggest that PDE5 downregulation in microvascular endothelium imparts a stable, enhanced angiogenic potential to this cell type.

          Related collections

          Author and article information

          Comments

          Comment on this article